孕前糖尿病孕妇尿液与血清血管生成标志物及子痫前期预测价值
该多中心前瞻性队列纳入158例孕前需胰岛素治疗的糖尿病孕妇(1型41例、2型117例),于孕14、24、30、36周检测尿PlGF与血清PlGF、sFLT-1及sFLT-1/PlGF比值。结果显示孕24周起尿与血清PlGF相关(P<0.001),子痫前期者各时点血清PlGF更低(P<0.05),血清PlGF预测优于sFLT-1/PlGF比值。
要点
- 孕24周起尿PlGF与血清PlGF相关(P<0.001)。
- 子痫前期者各时点血清PlGF更低(P<0.05)。
- 血清PlGF预测子痫前期优于sFLT-1/PlGF比值。
核心结论
- 孕前糖尿病孕妇中,血清PlGF预测子痫前期优于sFLT-1/PlGF比值。
- 孕24周起尿PlGF与血清PlGF相关。
研究设计与样本
- 多中心前瞻性队列研究,纳入158例孕前需胰岛素治疗的糖尿病孕妇(1型41例、2型117例)。
- 于孕14、24、30、36周共4次检测尿PlGF与血清PlGF、sFLT-1及sFLT-1/PlGF比值。
主要发现
- 孕24周起尿PlGF与血清PlGF相关(P<0.001)。
- 发生子痫前期者各时点血清PlGF水平更低(P<0.05)。
- 血清PlGF预测子痫前期优于sFLT-1/PlGF比值。
- 孕前HbA1c≥6.5%(48 mmol/mol)是子痫前期的重要判别预测因素(P=0.01)。
关键数值与推荐
- 孕前HbA1c≥6.5%(48 mmol/mol)与子痫前期相关(P=0.01)。
- 血清PlGF在各时点预测子痫前期优于sFLT-1/PlGF比值。
临床怎么用
- 孕前糖尿病孕妇可考虑系列监测血清PlGF以辅助子痫前期预测。
- 孕前HbA1c≥6.5%(48 mmol/mol)者应警惕子痫前期风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the correlation between urinary and serum placental growth factor (PlGF) and investigate the predictive value as pregnancy progresses of urinary PlGF compared with serum PlGF, soluble fms-like tyrosine kinase 1 (sFLT-1), and the sFLT-1-to-PlGF ratio for the outcome of preeclampsia in women with preexisting diabetes. RESEARCH DESIGN AND METHODS: A multicenter prospective cohort study was conducted of 158 women with preexisting insulin-requiring diabetes (41 with type 1 and 117 with type 2). Urinary PlGF and serum PlGF, sFLT-1, and the sFLT-1-to-PlGF ratio were assessed four times (14, 24, 30, and 36 weeks' gestation), and the association with the outcome of preeclampsia was investigated. RESULTS: A correlation between urinary and serum PlGF was demonstrated from 24 weeks' gestation onward (P < 0.001). At all time points, those who developed preeclampsia had lower serum PlGF levels (P < 0.05), and receiver operating characteristic curves demonstrated that serum PlGF in this cohort performed better than the serum sFLT-1-to-PlGF ratio as a predictive test for preeclampsia. Preconception HbA1c ≥6.5% (48 mmol/mol) was an important discriminative predictor for preeclampsia (P = 0.01). CONCLUSIONS: This study prospectively describes the longitudinal changes in urinary PlGF alongside serum angiogenic markers throughout pregnancy in women with preexisting diabetes. We demonstrate correlation between urinary and serum PlGF and that in women with preexisting diabetes in pregnancy, serum PlGF is a better predictor of preeclampsia than the sFLT-1-to-PlGF ratio.
引用
- Zen M, Padmanabhan S, Zhang K, et al. Urinary and Serum Angiogenic Markers in Women With Preexisting Diabetes During Pregnancy and Their Role in Preeclampsia Prediction. Diabetes Care. 2019. PMID: 31601637. doi:10.2337/dc19-0967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。